Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis.
Mimicos EV, Fossaluza V, Picone CM, de Sena CC, Gomes HR, Lázari CDS, Silva FFD, Nakanishi ES, Nisida IV, Freitas AC, Gryschek RB, Lagonegro ER, Lazéra M, Shikanai-Yasuda MA. Mimicos EV, et al. Among authors: freitas ac. J Fungi (Basel). 2022 Dec 8;8(12):1284. doi: 10.3390/jof8121284. J Fungi (Basel). 2022. PMID: 36547617 Free PMC article.
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil.
Vidal JE, Song AT, Matos ML, Bartmann D, Anjos GD, Miranda ÉJ, Freitas ÂC, Dalben Mde F, Santana C, Segurado AC, Barreto CC, Hernández AV. Vidal JE, et al. Among authors: freitas ac. Braz J Infect Dis. 2013 Jan-Feb;17(1):41-7. doi: 10.1016/j.bjid.2012.08.022. Epub 2013 Jan 5. Braz J Infect Dis. 2013. PMID: 23294644 Free PMC article.
403 results